These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 21733060)
1. Glucoregulatory effects and prolonged duration of action of davalintide: a novel amylinomimetic peptide. Mack CM; Smith PA; Athanacio JR; Xu K; Wilson JK; Reynolds JM; Jodka CM; Lu MG; Parkes DG Diabetes Obes Metab; 2011 Dec; 13(12):1105-13. PubMed ID: 21733060 [TBL] [Abstract][Full Text] [Related]
2. Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight. Mack CM; Soares CJ; Wilson JK; Athanacio JR; Turek VF; Trevaskis JL; Roth JD; Smith PA; Gedulin B; Jodka CM; Roland BL; Adams SH; Lwin A; Herich J; Laugero KD; Vu C; Pittner R; Paterniti JR; Hanley M; Ghosh S; Parkes DG Int J Obes (Lond); 2010 Feb; 34(2):385-95. PubMed ID: 19935749 [TBL] [Abstract][Full Text] [Related]
3. KBP-088, a novel DACRA with prolonged receptor activation, is superior to davalintide in terms of efficacy on body weight. Gydesen S; Andreassen KV; Hjuler ST; Christensen JM; Karsdal MA; Henriksen K Am J Physiol Endocrinol Metab; 2016 May; 310(10):E821-7. PubMed ID: 26908506 [TBL] [Abstract][Full Text] [Related]
4. Amylin receptors mediate the anorectic action of salmon calcitonin (sCT). Lutz TA; Tschudy S; Rushing PA; Scharrer E Peptides; 2000 Feb; 21(2):233-8. PubMed ID: 10764950 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight. Mack C; Wilson J; Athanacio J; Reynolds J; Laugero K; Guss S; Vu C; Roth J; Parkes D Am J Physiol Regul Integr Comp Physiol; 2007 Nov; 293(5):R1855-63. PubMed ID: 17855496 [TBL] [Abstract][Full Text] [Related]
6. Interactions of amylinergic and melanocortinergic systems in the control of food intake and body weight in rodents. Roth JD; D'Souza L; Griffin PS; Athanacio J; Trevaskis JL; Nazarbaghi R; Jodka C; Athanacio J; Hoyt J; Forood B; Parkes DG Diabetes Obes Metab; 2012 Jul; 14(7):608-15. PubMed ID: 22276636 [TBL] [Abstract][Full Text] [Related]
7. Pancreatic amylin as a centrally acting satiating hormone. Lutz TA Curr Drug Targets; 2005 Mar; 6(2):181-9. PubMed ID: 15777188 [TBL] [Abstract][Full Text] [Related]
8. Hypoglycemia overrides amylin-mediated regulation of gastric emptying in rats. Gedulin BR; Young AA Diabetes; 1998 Jan; 47(1):93-7. PubMed ID: 9421380 [TBL] [Abstract][Full Text] [Related]
9. Comparative effects of amylin and cholecystokinin on food intake and gastric emptying in rats. Reidelberger RD; Arnelo U; Granqvist L; Permert J Am J Physiol Regul Integr Comp Physiol; 2001 Mar; 280(3):R605-11. PubMed ID: 11171636 [TBL] [Abstract][Full Text] [Related]
10. Subdiaphragmatic vagotomy does not influence the anorectic effect of amylin. Lutz TA; Del Prete E; Scharrer E Peptides; 1995; 16(3):457-62. PubMed ID: 7651899 [TBL] [Abstract][Full Text] [Related]
11. Improved glucose control and reduced body weight in rodents with dual mechanism of action peptide hybrids. Trevaskis JL; Mack CM; Sun C; Soares CJ; D'Souza LJ; Levy OE; Lewis DY; Jodka CM; Tatarkiewicz K; Gedulin B; Gupta S; Wittmer C; Hanley M; Forood B; Parkes DG; Ghosh SS PLoS One; 2013; 8(10):e78154. PubMed ID: 24167604 [TBL] [Abstract][Full Text] [Related]
12. Response to intravenous injections of amylin and glucagon in fasted, fed, and hypoglycemic rats. Young AA; Cooper GJ; Carlo P; Rink TJ; Wang MW Am J Physiol; 1993 Jun; 264(6 Pt 1):E943-50. PubMed ID: 8333519 [TBL] [Abstract][Full Text] [Related]
13. The Dual Amylin and Calcitonin Receptor Agonist KBP-088 Induces Weight Loss and Improves Insulin Sensitivity Superior to Chronic Amylin Therapy. Larsen AT; Sonne N; Andreassen KV; Gehring K; Karsdal MA; Henriksen K J Pharmacol Exp Ther; 2019 Jul; 370(1):35-43. PubMed ID: 31028106 [TBL] [Abstract][Full Text] [Related]
14. Rodent models of leptin receptor deficiency are less sensitive to amylin. Duffy S; Lutz TA; Boyle CN Am J Physiol Regul Integr Comp Physiol; 2018 Oct; 315(4):R856-R865. PubMed ID: 30133304 [TBL] [Abstract][Full Text] [Related]
15. Control of food intake and energy expenditure by amylin-therapeutic implications. Lutz TA Int J Obes (Lond); 2009 Apr; 33 Suppl 1():S24-7. PubMed ID: 19363503 [TBL] [Abstract][Full Text] [Related]
16. Amylin and GLP-1 target different populations of area postrema neurons that are both modulated by nutrient stimuli. Züger D; Forster K; Lutz TA; Riediger T Physiol Behav; 2013 Mar; 112-113():61-9. PubMed ID: 23438370 [TBL] [Abstract][Full Text] [Related]
17. Biological activity of AC3174, a peptide analog of exendin-4. Hargrove DM; Kendall ES; Reynolds JM; Lwin AN; Herich JP; Smith PA; Gedulin BR; Flanagan SD; Jodka CM; Hoyt JA; McCowen KM; Parkes DG; Anderson CM Regul Pept; 2007 Jun; 141(1-3):113-9. PubMed ID: 17292977 [TBL] [Abstract][Full Text] [Related]
18. Infusion of the amylin antagonist AC 187 into the area postrema increases food intake in rats. Mollet A; Gilg S; Riediger T; Lutz TA Physiol Behav; 2004 Mar; 81(1):149-55. PubMed ID: 15059694 [TBL] [Abstract][Full Text] [Related]
19. Synergy between amylin and cholecystokinin for inhibition of food intake in mice. Bhavsar S; Watkins J; Young A Physiol Behav; 1998 Jun; 64(4):557-61. PubMed ID: 9761232 [TBL] [Abstract][Full Text] [Related]
20. Interaction of leptin and amylin in the long-term maintenance of weight loss in diet-induced obese rats. Trevaskis JL; Lei C; Koda JE; Weyer C; Parkes DG; Roth JD Obesity (Silver Spring); 2010 Jan; 18(1):21-6. PubMed ID: 19543217 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]